Leerink Swann Upgrades Amicus Therapeutics (FOLD) to Outperform
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Price: $10.82 +1.98%
Rating Summary:
14 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 8 | New: 36
Rating Summary:
14 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 8 | New: 36
Join SI Premium – FREE
Leerink Swann upgraded Amicus Therapeutics (NASDAQ: FOLD) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on Amicus Therapeutics click here. For more ratings news on Amicus Therapeutics click here.
Shares of Amicus Therapeutics closed at $3.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Upgrades Reckitt Benckiser (RKT:LN) (RBGLY) to Hold
- JPMorgan Upgrades TMBThanachart Bank PCL (TTB:TB) to Overweight
- BofA Securities Upgrades Sea Ltd. (SE) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
